| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/26/2006 | US20060240438 Surface of base material being inhibited in non-specific adsorption |
| 10/26/2006 | US20060240437 Predictors of renal disease |
| 10/26/2006 | US20060240436 Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) |
| 10/26/2006 | US20060240435 Polymerizing N,N'-dimethylacrylamide, sodium acrylate, acrylic acid, and polyethyleneglycol diacrylate in aqueous solution in the presence of the macromolecule (polypeptide, polynucleotide, sugar) and a 2,2'-azobis[2-(2-imidazolin-2-yl)propane] and removing the macromolecule from the polymer produced |
| 10/26/2006 | US20060240433 Facls as modifiers of the rb pathway and methods of use |
| 10/26/2006 | US20060240432 Transmembrane serine protease probes for use as evaluative tool in detection of nervous system stem cells and treatment of neurodegenerative diseases; regenerative medicine; tissue engineering |
| 10/26/2006 | US20060240429 Method of screening compound inhibiting enzymatic activity of gwt1 gene product |
| 10/26/2006 | US20060240427 Method for the detection of pathogenic gram positive bacteria from the genera staphylococcus, enterococcus and streptococcus |
| 10/26/2006 | US20060240426 Gene expression in biological conditions |
| 10/26/2006 | US20060240425 Genes and polypeptides relating to myeloid leukemia |
| 10/26/2006 | US20060240424 Regulation of human p2y15 g protein-coupled receptor |
| 10/26/2006 | US20060240422 Caspase 10 as target for monitoring and treatment of diseases |
| 10/26/2006 | US20060240416 Using magnetic particles comprising immobilized messenger RNA sequences to transform cells; reverse transcribing sequences, incorporating cDNA into vectors; recovering and pooling clones |
| 10/26/2006 | US20060240415 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 10/26/2006 | US20060240411 Multiplex microparticle system |
| 10/26/2006 | US20060240404 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 10/26/2006 | US20060240400 High-density cell array board, process for producing the same and method of using the same |
| 10/26/2006 | US20060240129 Skin tissue regeneration promoters comprising ginsenoside Rb1 |
| 10/26/2006 | US20060240058 Combinatorial surface chip compositions for selection, differentiation and propagation of cells |
| 10/26/2006 | US20060240044 Streptococcal superantigens spe-l and spe-m |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240035 Vmp-like sequences of pathogenic borrelia species and strains |
| 10/26/2006 | US20060240030 Anti-hiv immunogenic formulation and process for preparation thereof |
| 10/26/2006 | US20060240027 Conjugated with toxins, enzymes, radioactive compounds, and hematogenous cells; use in staging and diagnosis; treatment of metastasis |
| 10/26/2006 | US20060240024 T cell regulation |
| 10/26/2006 | US20060240023 Apoptosis-associated protein and use thereof |
| 10/26/2006 | US20060240019 Antagonists of HMG1 for treating inflammatory conditions |
| 10/26/2006 | US20060240018 Artificial antibody polypeptides |
| 10/26/2006 | US20060240013 Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) |
| 10/26/2006 | US20060240012 For treating inflammation and immunopathy; rheumatoid arthritis |
| 10/26/2006 | US20060240010 Methods of modulating CD200 receptors |
| 10/26/2006 | US20060240006 Novel antibody structures derived from human germline sequences |
| 10/26/2006 | US20060240004 Methods for treating tweak-related conditions |
| 10/26/2006 | US20060240002 Methods of inhibiting angiogenesis-dependent conditions mediated by cryptic epitopes of extracellular matrix components |
| 10/26/2006 | US20060239997 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 10/26/2006 | US20060239996 ANTIBODIES SPECIFIC FOR UNGULATE PrP |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239990 Protein Arginine N-Methyltransferase 2 (PRMT-2) |
| 10/26/2006 | US20060239980 Cartilage-derived stem cells and applications thereof |
| 10/26/2006 | US20060239978 Cellular expression of 65B13 in the neurons can be used as an index to select cells that are suitable in terms of their safety, survival rate, and network formation ability, for transplant therapy of neurodegenerative diseases such as Parkinson's disease |
| 10/26/2006 | US20060239968 method of delivering agent to prostate cancer tissue comprising obtaining peptide that selectively binds to prostate cancer tissue, where peptide is less than 100 amino acids in length and includes prostate cancer targeting motif having disclosed amino acid sequence; peptide is attached to target agent |
| 10/26/2006 | US20060239922 Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents |
| 10/26/2006 | US20060239912 Carrier molecules |
| 10/26/2006 | US20060239911 Antibodies with immune effector activity and that internalize in endosialin-positive cells |
| 10/26/2006 | US20060239910 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 10/26/2006 | US20060239864 comprising organized array or matrix of biopolymer probes for separation or analysis of molecular targets; device separates and/or detects plurality of molecular targets, especially nucleic acids or proteins, in solution in complex mixture |
| 10/26/2006 | US20060239862 Testing chip and micro analysis system |
| 10/26/2006 | US20060239859 Controlled flow assay device and method |
| 10/26/2006 | US20060239856 Vehicle ignition interlock systems with mouth alcohol contamination sensor |
| 10/26/2006 | US20060239533 Method for detecting infectious agents using computer controlled automated image analysis |
| 10/26/2006 | US20060238443 Simple matrix addressing in a display |
| 10/26/2006 | US20060237805 detectors comprising patterned carbon nanotubes having electrical properties on support structures so that it may be exposed to fluids and control circuits; analysis apparatus |
| 10/26/2006 | US20060237642 Explosives detection using differential mobility spectrometry |
| 10/26/2006 | US20060237546 Symmetric product identifying tags |
| 10/26/2006 | US20060237333 Method for the detection of carbon monoxide in a hydrogen-rich gas stream |
| 10/26/2006 | US20060237332 Electrochemical detection method |
| 10/26/2006 | US20060236794 Method and apparatus for determining the operating points of bone cement |
| 10/26/2006 | US20060236790 Device and method for measuring metal inclusions |
| 10/26/2006 | DE112004000212B4 Vorrichtung zur Eindeckung von histologischen und biologischen Proben Apparatus for covering of histological and biological samples |
| 10/26/2006 | DE10211358B4 Vertikal-Impedanz-Sensor-Anordnung und Verfahren zum Herstellen einer Vertikal-Impedanz-Sensor-Anordnung Vertical-impedance sensor arrangement and method of manufacturing a vertical-impedance sensor arrangement |
| 10/26/2006 | DE102005018845A1 Miniature multifunctional opto sensor control and lock unit for minimal invasive sensor location has measurement chamber and micrometer drive |
| 10/26/2006 | DE102005017817A1 Verfahren und Vorrichtung zur Untersuchung eines biologischen Gewebes Method and device for assaying a biological tissue |
| 10/26/2006 | DE102005017522A1 Hydrogel based biosensor chip immobilization and reaction matrix hydrogel includes a copolymerisation reaction product from methacrylamide based mixtures |
| 10/26/2006 | CA2606273A1 Rapid exchange luminescence (rel) for high sensitivity detection |
| 10/26/2006 | CA2606253A1 Pcr for mrsa sccmec typing |
| 10/26/2006 | CA2606156A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 10/26/2006 | CA2606136A1 Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test |
| 10/26/2006 | CA2605933A1 Method of identifying cd4+ t cell antigens |
| 10/26/2006 | CA2605493A1 Immobilisation of antigenic carbohydrates to support detection of pathogenic micro-organisms |
| 10/26/2006 | CA2605440A1 Method of determining the point at which coagulating blood forms a clot |
| 10/26/2006 | CA2605410A1 A therapeutic agent for a .beta. related disorders |
| 10/26/2006 | CA2605178A1 Debulking catheters and methods |
| 10/26/2006 | CA2605143A1 Diagnosis of sepsis |
| 10/26/2006 | CA2604922A1 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 10/26/2006 | CA2604691A1 Method for porcine circovirus production and assays for monitoring production |
| 10/26/2006 | CA2604675A1 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products |
| 10/26/2006 | CA2604631A1 Methods of enhancing isolation of rna from biological samples |
| 10/26/2006 | CA2604580A1 Methods for modulating bone formation and mineralization by modulating krc activity |
| 10/26/2006 | CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof |
| 10/26/2006 | CA2604323A1 Fluidic structures including meandering and wide channels |
| 10/26/2006 | CA2604258A1 Device and method for ultrasonically determining the dynamic elastic modulus of a material |
| 10/26/2006 | CA2604168A1 Test medium comprising an indicator for rapid analysis of functional fluids |
| 10/26/2006 | CA2603814A1 Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment |
| 10/26/2006 | CA2603794A1 Syphilis diagnostic test and kits |
| 10/26/2006 | CA2603303A1 Use of phosphonazo iii for the measurement of calcium, magnesium and sodium in analytical samples |
| 10/26/2006 | CA2602635A1 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 10/25/2006 | EP1715357A1 Nmr signal assignment method |
| 10/25/2006 | EP1715347A1 Method of protein measurement |
| 10/25/2006 | EP1715346A1 Method of identifying CD4+ T cell antigens |
| 10/25/2006 | EP1715345A1 A reagent for partially lysing a cell membrane of a red blood cell, a reagent for detecting malaria infected red blood cells, and a sample analyzing method for detecting malaria infected red blood cells |
| 10/25/2006 | EP1715344A1 Immobilisation of antigenic carbohydrates to support detection of pathogenic micro-organisms |
| 10/25/2006 | EP1715343A1 Method for the identification of epitopes related to immunogenicity in biopharmaceuticals |
| 10/25/2006 | EP1715342A1 Binding assay using antigens embedded in thermoplastic |
| 10/25/2006 | EP1715341A1 Method and apparatus for determining the concentrations of at least 2 ligands. |
| 10/25/2006 | EP1715340A2 Method and apparatus for making an array for rapid molecular profiling |
| 10/25/2006 | EP1715338A2 Exhaust gas component analyzer |
| 10/25/2006 | EP1715334A1 Procedure utilising an electrochemical sensor and electrodes forming the sensor |
| 10/25/2006 | EP1715330A1 Liquid type identification device |
| 10/25/2006 | EP1715323A1 Method for determining the concentration and/or size distribution of solid particles in middle distillate fuels |
| 10/25/2006 | EP1715064A1 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |